Cited by 72Endometriosis Research and TreatmentEstrogen and related hormone effectsReproductive Biology and Fertility

Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis

Open access
Utsunomiya, Hiroki, Cheng, You-Hong, Lin, Zhihong, Reierstad, Scott, Yin, Ping, Attar, Erkut, Xue, Qing, Imir, Gonca +7 more·2008·Molecular Endocrinology

Abstract

Local estrogen biosynthesis is a major factor in the pathogenesis of endometriosis. Aberrant expression of steroidogenic acute regulatory protein (StAR) and aromatase in endometriotic tissue leads to an up-regulation of estrogen production. The transcription factor steroidogenic factor-1 (SF-1) activates the promoters of both StAR and aromatase in endometriotic tissue. We investigated differences in SF-1 expression in endometriotic tissue and normally located endometrium to elucidate the mechanism underlying increased StAR and aromatase activities in endometriosis. Serial deletion and site-directed mutants of the SF-1 promoter showed that an E-box sequence was critical for its activity in endometriotic stromal cells. EMSAs showed that the upstream stimulatory factor (USF) 1 and 2 in nuclear extracts from endometrial and endometriotic stromal cells bound to the E-box. Chromatin-immunoprecipitation-PCR assay, however, demonstrated in intact cells that binding activity of USF2 to the SF-1 promoter was strikingly higher than that of USF1 in endometriotic stromal cells and that USF1 or USF2 binding activity was hardly detectable in endometrial stromal cells. Moreover, knockdown of USF2 but not USF1 resulted in robust and consistent down-regulation of SF-1 and its target genes StAR and aromatase in endometriotic stromal cells. USF2 but not USF1 mRNA and protein levels were significantly higher in endometriotic vs. endometrial stromal cells. In vivo, USF2 mRNA and immunoreactive USF2 levels in endometriotic tissues were strikingly higher than those in endometrium. Taken together, the elevated levels of USF2 in endometriosis account for, in part, the aberrant expression of SF-1 and its target gene StAR and aromatase.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/me.2006-0302

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 37 · Cited by 72

Authors
Utsunomiya, H., Cheng, Y.-H., Lin, Z., Reierstad, S., Yin, P., Attar, E., Xue, Q., Imir, G., Thung, S., Trukhacheva, E., Suzuki, T., Sasano, H., Kim, J. J., Yaegashi, N., & Bulun, S. E.
Affiliations
  • Northwestern University (US)
  • Division of Reproductive Biology Research (H.U., Y.-H.C., Z.L., S.R., P.Y., E.A., Q.X., G.I., S.T., E.T., J.J.K., S.E.B.), Department of Obstetrics and Gynecology, Feinberg School of Medicine at Northwestern University, Illinois 60611
  • Departments of Pathology (T.S., H.S.), 980-8574 Sendai, Japan
  • Tohoku University (JP)
Corresponding author
Bulun, Serdar E.
Venue
Molecular Endocrinology
Published
2008-04-01
Volume
22
Issue
4
Pages
904-914
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W1964803062
Cited by
72
References
37
Citations by year
2025: 2 · 2024: 2 · 2023: 5 · 2022: 2 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 6 · 2012: 7
FWCI
8.84
Type
journal article
Language
en
Open access
Locations
  • Molecular Endocrinology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Avon Foundation for Women
  • Northwestern University
  • National Institutes of Health
  • Feinberg School of Medicine
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD044715, HD38961)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
endometriosis, steroidogenic factor 1, upstream stimulatory factor 1, steroidogenic acute regulatory protein, aromatase, estrogen synthesis, E-box, transcriptional regulation, endometriotic stromal cells, promoter regulation
MeSH terms
Aromatase, Cells, Cultured, Endometriosis, Endometrium, Female, Humans, Immunohistochemistry, Promoter Regions, Genetic, RNA, Messenger, Transcription, Genetic, Transfection, Immunoblotting, Gene Expression, Stromal Cells, Reverse Transcriptase Polymerase Chain Reaction, RNA, Small Interfering, Chromatin Immunoprecipitation, Upstream Stimulatory Factors, Steroidogenic Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review